Product Code: 4435
The animal model market is projected to witness exponential growth by 2028 due to increasing pharmaceutical research and development activities around the world.
Surging number of investigators and institutions globally are employing a variety of large and small animal models to investigate key features of COVID-19, such as pathology, transmission, and host responses to SARS-CoV-2. Moreover, animal models are also being adopted to assess the safety and efficacy of prospective treatment drugs and vaccinations, which has augmented industry expansion.
The animal model market has been segregated based on end use, animal type, use, technology, application, and region. With respect to animal type, the market has further been classified into hamsters, mice, sheep, rats, monkeys, fish, rabbits, birds, cats, cattles, dogs, pigs, guinea pigs, amphibians, and others. In 2021, the pigs sub-segment was worth more than USD 669 million and is slated to expand at a CAGR of approximately 5.0% over the analysis period. This growth is attributed to the similarity of pigs to humans in terms of genetics, physiology, and anatomy.
From the technology perspective, the animal model market has been bifurcated into laser therapy, CRISPR, nuclear transfer, microinjection, embryonic stem cell injection, and others. The embryonic stem cell injection sub-segment held a valuation of nearly USD 2,787 million in 2021 and is anticipated to progress at a CAGR of around 8.2% through the projected timeline. Embryonic stem cell injection offers several advantages, including cost-effectiveness, easy transfer of genetic material, and timesaving, among others, which is set to boost segmental development in the coming time period.
Based on application, the market has been segmented into preclinical applications, research & development, academics, production and quality control, and others. The animal model market size from the academics sub-segment surpassed USD 315 million in revenue in 2021 and is speculated to witness robust growth through 2028, registering a CAGR of above 9.2% between 2022 and 2028. Growing research activities in colleges and other institutions are likely to bolster segmental expansion.
By use, the animal model market has been divided into veterinary and human. In 2021, the veterinary sub-segment exceeded a valuation of USD 3,451 million and is estimated to grow at about 7.8% CAGR through the review period. Rising prevalence of fatal animal disorders is set to propel segmental progress.
In terms of end-use, the animal model market has been categorized into contract research organizations (CRO), companies, academic and research institutes, and organizations. In 2021, the contract research organizations (CRO) sub-segment garnered a revenue worth USD 1,340 million and is projected to develop at a CAGR of approximately 8.1% over the assessment period. Increasing R&D expenditure and growing number of clinical trials in emerging countries are estimated to drive product uptake in CROs over the forthcoming years.
On the regional front, the Latin America animal model market was valued at around USD 119 million in 2021 and is expected to expand at a sturdy growth rate of nearly 8.0% through the forecast period. Mounting healthcare expenditure, along with rising scientific research activities, is set to foster regional market outlook.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definition
- 1.2 Base estimates & working
- 1.3 Forecast parameters
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Animal model industry 360 degree synopsis, 2017 - 2028
- 2.1.1 Business trends
- 2.1.2 Animal type trends
- 2.1.3 Technology trends
- 2.1.4 Application trends
- 2.1.5 Use trends
- 2.1.6 End-use trends
- 2.1.7 Regional trends
Chapter 3 Animal Model Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2017 - 2028 (USD Million)
- 3.3 Industry impact factors
- 3.3.1 Growth drivers
- 3.3.1.1 Growing number of pharmaceutical research and development activities
- 3.3.1.2 Large number of applications in healthcare domain
- 3.3.1.3 Physiological similarities between human and animal
- 3.3.1.4 Emergence of CRISPR as a powerful tool in the field of biomedical research
- 3.3.1.5 Growing consumption of personalized medicine driving the demand for humanized mice models
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 Expensive process
- 3.3.2.2 Strict regulations and guidelines
- 3.3.2.3 Growing opposition on animal testing by several organizations
- 3.4 Growth potential analysis
- 3.4.1 By animal type
- 3.4.2 By technology
- 3.4.3 By application
- 3.4.4 By use
- 3.4.5 By End-use
- 3.5 COVID-19 impact analysis
- 3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
- 3.6.3 Asia Pacific
- 3.6.4 Latin America
- 3.6.5 Middle East & Africa
- 3.7 Porter's analysis
- 3.8 Pricing analysis
- 3.9 Competitive landscape, 2021
- 3.9.1 Competitive matrix analysis, 2021
- 3.10 PESTEL analysis
Chapter 4 Animal Model Market, By Animal Type
- 4.1 Key segment trends
- 4.2 Mice
- 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.2.2 Market size, by region, 2017 - 2028 (Units)
- 4.3 Rats
- 4.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.3.2 Market size, by region, 2017 - 2028 (Units)
- 4.4 Fish
- 4.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.4.2 Market size, by region, 2017 - 2028 (Units)
- 4.5 Birds
- 4.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.5.2 Market size, by region, 2017 - 2028 (Units)
- 4.6 Cattles
- 4.6.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.6.2 Market size, by region, 2017 - 2028 (Units)
- 4.7 Pigs
- 4.7.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.7.2 Market size, by region, 2017 - 2028 (Units)
- 4.8 Amphibians
- 4.8.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.8.2 Market size, by region, 2017 - 2028 (Units)
- 4.9 Guinea Pigs
- 4.9.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.9.2 Market size, by region, 2017 - 2028 (Units)
- 4.10 Dogs
- 4.10.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.10.2 Market size, by region, 2017 - 2028 (Units)
- 4.11 Cats
- 4.11.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.11.2 Market size, by region, 2017 - 2028 (Units)
- 4.12 Rabbits
- 4.12.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.12.2 Market size, by region, 2017 - 2028 (Units)
- 4.13 Monkeys
- 4.13.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.13.2 Market size, by region, 2017 - 2028 (Units)
- 4.14 Sheep
- 4.14.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.14.2 Market size, by region, 2017 - 2028 (Units)
- 4.15 Hamsters
- 4.15.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.15.2 Market size, by region, 2017 - 2028 (Units)
- 4.16 Others
- 4.16.1 Market size, by region, 2017 - 2028 (USD Million)
- 4.16.2 Market size, by region, 2017 - 2028 (Units)
Chapter 5 Animal Model Market, By Technology
- 5.1 Key segment trends
- 5.2 CRISPR
- 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.3 Microinjection
- 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.4 Embryonic Stem Cell Injection
- 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.5 Nuclear Transfer
- 5.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 5.6 Others
- 5.6.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 Animal Model Market, By Application
- 6.1 Key segment trends
- 6.2 Research & Development
- 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.2 Infectious Disease
- 6.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.3 Immunological Disease
- 6.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.4 Cancer
- 6.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.5 Cardiovascular Disease
- 6.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.6 Diabetes
- 6.2.6.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.7 Genetic Disease
- 6.2.7.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.8 Neurological Disease
- 6.2.8.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.9 Obesity
- 6.2.9.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.10 NAFLD/NASH
- 6.2.10.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.11 Renal Disease
- 6.2.11.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.12 Diabetic Eye Disease
- 6.2.12.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.13 Fibrosis
- 6.2.13.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.14 Microbiome
- 6.2.14.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.2.15 Others
- 6.2.15.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.3 Production & Quality Control
- 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.4 Academics
- 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5 Preclinical Applications
- 6.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.2 Infectious Disease
- 6.5.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.3 Immunological Disease
- 6.5.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.4 Cancer
- 6.5.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.5 Cardiovascular Disease
- 6.5.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.6 Diabetes
- 6.5.6.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.7 Genetic Disease
- 6.5.7.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.8 Neurological Disease
- 6.5.8.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.9 Obesity
- 6.5.9.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.10 NAFLD/NASH
- 6.5.10.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.11 Renal Disease
- 6.5.11.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.12 Diabetic Eye Disease
- 6.5.12.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.13 Fibrosis
- 6.5.13.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.14 Microbiome
- 6.5.14.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.5.15 Others
- 6.5.15.1 Market size, by region, 2017 - 2028 (USD Million)
- 6.6 Others
- 6.6.1.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 7 Animal Model Market, By Use
- 7.1 Key segment trends
- 7.2 Human
- 7.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 7.3 Veterinary
- 7.3.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 8 Animal Model Market, By End-use
- 8.1 Key segment trends
- 8.2 Companies
- 8.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.2.2 Pharmaceutical
- 8.2.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.2.3 Biotechnology
- 8.2.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.2.4 Cosmetics
- 8.2.4.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.2.5 Others
- 8.2.5.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.3 Organizations
- 8.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.3.2 Government
- 8.3.2.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.3.3 Non-government
- 8.3.3.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.4 Academic & Research Institutes
- 8.4.1.1 Market size, by region, 2017 - 2028 (USD Million)
- 8.5 Contract Research Organizations
- 8.5.1.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 9 Animal Model Market, By Region
- 9.1 Key regional trends
- 9.2 North America
- 9.2.1 Market size, by country, 2017 - 2028 (USD Million)
- 9.2.2 Market size, by country, 2017 - 2028 (Units)
- 9.2.3 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.2.4 Market size, by animal type, 2017 - 2028 (Units)
- 9.2.5 Market size, by technology, 2017 - 2028 (USD Million)
- 9.2.6 Market size, by application, 2017 - 2028 (USD Million)
- 9.2.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.2.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.2.7 Market size, by use, 2017 - 2028 (USD Million)
- 9.2.8 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.2.8.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.2.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.2.9 U.S.
- 9.2.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.2.9.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.2.9.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.2.9.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.2.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.2.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.2.9.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.2.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.2.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.2.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.2.10 Canada
- 9.2.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.2.10.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.2.10.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.2.10.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.2.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.2.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.2.10.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.2.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.2.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.2.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3 Europe
- 9.3.1 Market size, by country, 2017 - 2028 (USD Million)
- 9.3.2 Market size, by country, 2017 - 2028 (Units)
- 9.3.3 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.4 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.5 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.6 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.7 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.8 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.8.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.9 Germany
- 9.3.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.9.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.9.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.9.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.9.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.10 UK
- 9.3.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.10.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.10.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.10.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.10.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.11 France
- 9.3.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.11.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.11.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.11.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.11.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.12 Spain
- 9.3.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.12.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.12.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.12.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.12.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.13 Italy
- 9.3.13.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.13.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.13.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.13.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.13.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.13.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.13.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.13.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.13.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.13.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.14 Switzerland
- 9.3.14.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.14.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.14.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.14.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.14.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.14.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.14.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.14.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.14.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.14.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.15 Netherlands
- 9.3.15.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.15.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.15.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.15.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.15.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.15.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.15.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.15.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.15.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.15.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.16 Czech Republic
- 9.3.16.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.16.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.16.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.16.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.16.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.16.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.16.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.16.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.16.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.16.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.17 Poland
- 9.3.17.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.17.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.17.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.17.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.17.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.17.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.17.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.17.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.17.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.17.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.18 Belgium
- 9.3.18.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.18.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.18.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.18.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.18.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.18.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.18.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.18.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.18.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.18.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.19 Finland
- 9.3.19.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.19.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.19.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.19.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.19.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.19.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.19.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.19.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.19.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.19.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.20 Hungary
- 9.3.20.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.20.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.20.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.20.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.20.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.20.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.20.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.20.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.20.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.20.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.21 Denmark
- 9.3.21.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.21.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.21.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.21.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.21.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.21.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.21.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.21.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.21.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.21.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.22 Ireland
- 9.3.22.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.22.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.22.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.22.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.22.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.22.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.22.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.22.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.22.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.22.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.3.23 Sweden
- 9.3.23.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.3.23.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.3.23.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.3.23.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.3.23.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.3.23.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.3.23.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.3.23.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.3.23.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.3.23.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4 Asia Pacific
- 9.4.1 Market size, by country, 2017 - 2028 (USD Million)
- 9.4.2 Market size, by country, 2017 - 2028 (Units)
- 9.4.3 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.4 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.5 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.6 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.7 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.8 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.8.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.9 China
- 9.4.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.9.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.9.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.9.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.9.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.10 Japan
- 9.4.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.10.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.10.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.10.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.10.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.11 Australia
- 9.4.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.11.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.11.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.11.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.11.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.12 South Korea
- 9.4.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.12.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.12.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.12.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.12.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.13 New Zealand
- 9.4.13.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.13.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.13.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.13.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.13.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.13.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.13.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.13.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.13.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.13.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.4.14 Taiwan
- 9.4.14.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.4.14.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.4.14.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.4.14.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.4.14.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.4.14.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.4.14.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.4.14.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.4.14.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.4.14.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.5 Latin America
- 9.5.1 Market size, by country, 2017 - 2028 (USD Million)
- 9.5.2 Market size, by country, 2017 - 2028 (Units)
- 9.5.3 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.5.4 Market size, by animal type, 2017 - 2028 (Units)
- 9.5.5 Market size, by technology, 2017 - 2028 (USD Million)
- 9.5.6 Market size, by application, 2017 - 2028 (USD Million)
- 9.5.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.5.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.5.7 Market size, by use, 2017 - 2028 (USD Million)
- 9.5.8 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.5.8.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.5.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.5.9 Brazil
- 9.5.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.5.9.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.5.9.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.5.9.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.5.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.5.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.5.9.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.5.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.5.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.5.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.5.10 Mexico
- 9.5.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.5.10.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.5.10.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.5.10.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.5.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.5.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.5.10.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.5.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.5.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.5.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.5.11 Argentina
- 9.5.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.5.11.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.5.11.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.5.11.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.5.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.5.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.5.11.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.5.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.5.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.5.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.6 Middle East & Africa
- 9.6.1 Market size, by country, 2017 - 2028 (USD Million)
- 9.6.2 Market size, by country, 2017 - 2028 (Units)
- 9.6.3 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.6.4 Market size, by animal type, 2017 - 2028 (Units)
- 9.6.5 Market size, by technology, 2017 - 2028 (USD Million)
- 9.6.6 Market size, by application, 2017 - 2028 (USD Million)
- 9.6.6.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.6.6.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.6.7 Market size, by use, 2017 - 2028 (USD Million)
- 9.6.8 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.6.8.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.6.8.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.6.9 South Africa
- 9.6.9.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.6.9.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.6.9.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.6.9.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.6.9.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.6.9.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.6.9.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.6.9.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.6.9.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.6.9.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.6.10 Saudi Arabia
- 9.6.10.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.6.10.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.6.10.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.6.10.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.6.10.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.6.10.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.6.10.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.6.10.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.6.10.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.6.10.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.6.11 UAE
- 9.6.11.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.6.11.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.6.11.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.6.11.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.6.11.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.6.11.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.6.11.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.6.11.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.6.11.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.6.11.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
- 9.6.12 Israel
- 9.6.12.1 Market size, by animal type, 2017 - 2028 (USD Million)
- 9.6.12.2 Market size, by animal type, 2017 - 2028 (Units)
- 9.6.12.3 Market size, by technology, 2017 - 2028 (USD Million)
- 9.6.12.4 Market size, by application, 2017 - 2028 (USD Million)
- 9.6.12.4.1 Market size, by research & development, 2017 - 2028 (USD Million)
- 9.6.12.4.2 Market size, by preclinical applications, 2017 - 2028 (USD Million)
- 9.6.12.5 Market size, by use, 2017 - 2028 (USD Million)
- 9.6.12.6 Market size, by end-use, 2017 - 2028 (USD Million)
- 9.6.12.6.1 Market size, by companies, 2017 - 2028 (USD Million)
- 9.6.12.6.2 Market size, by organizations, 2017 - 2028 (USD Million)
Chapter 10 Company Profiles
- 10.1 Competitive dashboard, 2021
- 10.2 Charles River
- 10.2.1 Business overview
- 10.2.2 Financial data
- 10.2.3 Product landscape
- 10.2.4 Strategic outlook
- 10.2.5 SWOT analysis
- 10.3 Envigo
- 10.3.1 Business overview
- 10.3.2 Financial data
- 10.3.3 Product landscape
- 10.3.4 Strategic outlook
- 10.3.5 SWOT analysis
- 10.4 genOway
- 10.4.1 Business overview
- 10.4.2 Financial data
- 10.4.3 Product landscape
- 10.4.4 Strategic outlook
- 10.4.5 SWOT analysis
- 10.5 Harbour BioMed
- 10.5.1 Business overview
- 10.5.2 Financial data
- 10.5.3 Product landscape
- 10.5.4 Strategic outlook
- 10.5.5 SWOT analysis
- 10.6 Janvier Labs
- 10.6.1 Business overview
- 10.6.2 Financial data
- 10.6.3 Product landscape
- 10.6.4 Strategic outlook
- 10.6.5 SWOT analysis
- 10.7 PharmaLegacy
- 10.7.1 Business overview
- 10.7.2 Financial data
- 10.7.3 Product landscape
- 10.7.4 Strategic outlook
- 10.7.5 SWOT analysis
- 10.8 Taconic Biosciences Inc.
- 10.8.1 Business overview
- 10.8.2 Financial data
- 10.8.3 Product landscape
- 10.8.4 Strategic outlook
- 10.8.5 SWOT analysis
- 10.9 The Jackson Laboratory
- 10.9.1 Business overview
- 10.9.2 Financial data
- 10.9.3 Product landscape
- 10.9.4 Strategic outlook
- 10.9.5 SWOT analysis
- 10.10 TRANS GENIC INC, Ltd.
- 10.10.1 Business overview
- 10.10.2 Financial data
- 10.10.3 Product landscape
- 10.10.4 Strategic outlook
- 10.10.5 SWOT analysis